OTSKY
Price
$25.97
Change
+$0.12 (+0.46%)
Updated
Aug 7 closing price
Capitalization
20.6B
82 days until earnings call
SNPHY
Price
$10.55
Change
-$0.73 (-6.47%)
Updated
Aug 7 closing price
Capitalization
3.26B
Interact to see
Advertisement

OTSKY vs SNPHY

Header iconOTSKY vs SNPHY Comparison
Open Charts OTSKY vs SNPHYBanner chart's image
Otsuka Holdings
Price$25.97
Change+$0.12 (+0.46%)
Volume$37.83K
Capitalization20.6B
Santen Pharmaceutical
Price$10.55
Change-$0.73 (-6.47%)
Volume$4.26K
Capitalization3.26B
OTSKY vs SNPHY Comparison Chart in %
Loading...
OTSKY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNPHY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OTSKY vs. SNPHY commentary
Aug 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OTSKY is a Buy and SNPHY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 09, 2025
Stock price -- (OTSKY: $25.97 vs. SNPHY: $10.55)
Brand notoriety: OTSKY and SNPHY are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: OTSKY: 63% vs. SNPHY: 99%
Market capitalization -- OTSKY: $20.6B vs. SNPHY: $3.26B
OTSKY [@Pharmaceuticals: Major] is valued at $20.6B. SNPHY’s [@Pharmaceuticals: Major] market capitalization is $3.26B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OTSKY’s FA Score shows that 1 FA rating(s) are green whileSNPHY’s FA Score has 0 green FA rating(s).

  • OTSKY’s FA Score: 1 green, 4 red.
  • SNPHY’s FA Score: 0 green, 5 red.
According to our system of comparison, OTSKY is a better buy in the long-term than SNPHY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OTSKY’s TA Score shows that 5 TA indicator(s) are bullish while SNPHY’s TA Score has 3 bullish TA indicator(s).

  • OTSKY’s TA Score: 5 bullish, 5 bearish.
  • SNPHY’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, OTSKY is a better buy in the short-term than SNPHY.

Price Growth

OTSKY (@Pharmaceuticals: Major) experienced а +9.58% price change this week, while SNPHY (@Pharmaceuticals: Major) price change was -4.34% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -0.68%. For the same industry, the average monthly price growth was +6.07%, and the average quarterly price growth was +13.67%.

Reported Earning Dates

OTSKY is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-0.68% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OTSKY($20.6B) has a higher market cap than SNPHY($3.26B). OTSKY has higher P/E ratio than SNPHY: OTSKY (16.86) vs SNPHY (15.60). SNPHY YTD gains are higher at: 4.249 vs. OTSKY (-4.452). OTSKY has higher annual earnings (EBITDA): 322B vs. SNPHY (17.2B). OTSKY has more cash in the bank: 506B vs. SNPHY (62.3B). SNPHY has less debt than OTSKY: SNPHY (40.1B) vs OTSKY (191B). OTSKY has higher revenues than SNPHY: OTSKY (1.81T) vs SNPHY (270B).
OTSKYSNPHYOTSKY / SNPHY
Capitalization20.6B3.26B631%
EBITDA322B17.2B1,872%
Gain YTD-4.4524.249-105%
P/E Ratio16.8615.60108%
Revenue1.81T270B669%
Total Cash506B62.3B812%
Total Debt191B40.1B476%
FUNDAMENTALS RATINGS
OTSKY vs SNPHY: Fundamental Ratings
OTSKY
SNPHY
OUTLOOK RATING
1..100
1050
VALUATION
overvalued / fair valued / undervalued
1..100
32
Undervalued
34
Fair valued
PROFIT vs RISK RATING
1..100
55100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
5049
P/E GROWTH RATING
1..100
9889
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OTSKY's Valuation (32) in the null industry is in the same range as SNPHY (34). This means that OTSKY’s stock grew similarly to SNPHY’s over the last 12 months.

OTSKY's Profit vs Risk Rating (55) in the null industry is somewhat better than the same rating for SNPHY (100). This means that OTSKY’s stock grew somewhat faster than SNPHY’s over the last 12 months.

OTSKY's SMR Rating (100) in the null industry is in the same range as SNPHY (100). This means that OTSKY’s stock grew similarly to SNPHY’s over the last 12 months.

SNPHY's Price Growth Rating (49) in the null industry is in the same range as OTSKY (50). This means that SNPHY’s stock grew similarly to OTSKY’s over the last 12 months.

SNPHY's P/E Growth Rating (89) in the null industry is in the same range as OTSKY (98). This means that SNPHY’s stock grew similarly to OTSKY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
OTSKYSNPHY
RSI
ODDS (%)
Bearish Trend 2 days ago
66%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
71%
Bullish Trend 2 days ago
63%
Momentum
ODDS (%)
Bullish Trend 2 days ago
56%
Bearish Trend 2 days ago
69%
MACD
ODDS (%)
Bullish Trend 2 days ago
56%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
61%
Bearish Trend 2 days ago
69%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
59%
Bearish Trend 2 days ago
70%
Advances
ODDS (%)
Bullish Trend 2 days ago
60%
Bullish Trend 26 days ago
56%
Declines
ODDS (%)
Bearish Trend 9 days ago
70%
Bearish Trend 9 days ago
67%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
65%
Bullish Trend 2 days ago
77%
Aroon
ODDS (%)
Bearish Trend 2 days ago
57%
Bearish Trend 2 days ago
70%
View a ticker or compare two or three
Interact to see
Advertisement
OTSKY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNPHY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TILCX23.75N/A
N/A
T. Rowe Price Lrg Cp Va I
MMBDX12.15N/A
N/A
MassMutual Balanced A
SMEYX16.27N/A
N/A
Invesco Small Cap Equity Y
MSGCX10.51N/A
N/A
Meridian Small Cap Growth C
JUEQX26.75N/A
N/A
JPMorgan US Equity R4

OTSKY and

Correlation & Price change

A.I.dvisor indicates that over the last year, OTSKY has been loosely correlated with OPHLY. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if OTSKY jumps, then OPHLY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OTSKY
1D Price
Change %
OTSKY100%
+0.46%
OPHLY - OTSKY
41%
Loosely correlated
-0.45%
DSNKY - OTSKY
37%
Loosely correlated
-1.48%
CHGCY - OTSKY
33%
Poorly correlated
-19.99%
ALPMY - OTSKY
22%
Poorly correlated
+0.67%
AMRN - OTSKY
22%
Poorly correlated
+0.33%
More

SNPHY and

Correlation & Price change

A.I.dvisor tells us that SNPHY and RHHBF have been poorly correlated (+9% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SNPHY and RHHBF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNPHY
1D Price
Change %
SNPHY100%
-6.46%
RHHBF - SNPHY
9%
Poorly correlated
N/A
RHHVF - SNPHY
9%
Poorly correlated
+0.37%
RHHBY - SNPHY
6%
Poorly correlated
+0.68%
OTSKY - SNPHY
3%
Poorly correlated
+0.46%
SNPHF - SNPHY
1%
Poorly correlated
N/A
More